IFS Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
IFS Advisors's AZN Position: Q3 2026 in Review
IFS Advisors opened a new position in AstraZeneca (AZN) in Q3 2026: 6 shares worth $968. The stake represents ﹤0.01% of the portfolio and ranks #428 among its holdings.
1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- IFS Advisors held 6 shares of AstraZeneca worth $968 as of Q3 2026.
- AstraZeneca was a new IFS Advisors position in Q3 2026.
- AstraZeneca made up ﹤0.01% of IFS Advisors's portfolio in Q3 2026, its #428 holding.
- 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on IFS Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.